Dr. Natan Bar-Chama: “Men Unable to Produce Sperm Might Have Higher Risk of Cancer”
Male infertility costs men more than just the ability to reproduce – it could also cost them their lives. Interfile men, especially those who are unable to produce sperm in their ejaculate, may be nearly two-times more likely to develop cancer than the general population, according to a new study published in Fertility and Sterility. This is the first study to suggest that azoospermia is associated with an increased risk of cancer. Future research should look at the benefits of having azoospermic men screened for cancer more often. "What I would like to see from this study is that, if a couple has infertility, and the male is diagnosed as a contributing factor, that an evaluation should be performed to detect other serious medical concerns," said Natan Bar-Chama, MD, Director of Male Reproductive Medicine and Surgery at The Mount Sinai Medical Center. “The emphasis at a fertility clinic is on the woman, and the technology is so effective that pregnancy becomes possible. But the male is often not inspected. Because of the effectiveness of technology with fertility, the male is very often bypassed during the evaluation." Learn more
Immunotherapy After Bladder Cancer Surgery Shows Excellent Cancer-free Survival Rates
May 14, 2022 View All Press ReleasesMount Sinai Receives $1 Million Grant for Prostate Cancer Research
Dec 05, 2019 View All Press Releases